RCC is a highly vascularized malignant tumor, the pathogenesis of which involves inactivation of the VHL gene, which promotes high expression of the most important vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), transforming growth factor, and other proteins associated with neovascularization. This evidence concerns the gene VHL and renal cell carcinoma.